Pyridino[1,2-a]pyrimidin-4-one compounds as anticancer agents
US7326711B2 · kind B2 · utility
23Cited by
5References
21Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 17, 2004 |
| Grant date | Feb 5, 2008 |
| Priority date | — |
| Expiry date | Oct 6, 2025 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Pyridin[1,2-a]pyrimidinyl compounds, pharmaceutically acceptable salts, and prodrugs thereof; compositions that include a pharmaceutically acceptable carrier and one or more of the pyridino[1,2-a]pyrimidinyl compounds, either alone or in combination with at least one additional therapeutic agent. Methods of using the pyridino[1,2-a]pyrimidinyl compounds, either alone or in combination with at least one additional therapeutic agent, in the prophylaxis or treatment of proliferative diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.